Rates of both MCI and composite of MCI or probable dementia lower with intensive treatment in extended follow-up study.
The findings of a recent study have brought new clarity to the discussion on short-term hormone therapy and its cognitive implications. This study followed participants from the Kronos Early Estrogen ...
Statins help people manage high cholesterol levels, but many experts want to know if these drugs can also support brain ...
CBT-E is a promising treatment for adolescents with eating disorders who did not fully recover from FBT or could not engage ...
The FDA approves a new maintenance dosing regimen for lecanemab (Leqembi; Eisai) in patients with early-stage Alzheimer ...
11d
GlobalData on MSNTisento doses first subject in Phase IIb study of zagociguat for MELAS treatmentTisento Therapeutics has dosed the first subject in its Phase IIb PRIZM study, examining the effects of the oral ...
11d
GlobalData on MSNEisai and Biogen’s Leqembi sBLA set for Alzheimer’s maintenance dosingThe US Food and Drug Administration has approved the supplemental biologics licence application (sBLA) of Eisai and Biogen's ...
Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatmentAlzheimer's disease progression does ...
A study by the (UPV/EHU) demonstrates that the drug WIN55,212-2 protects the brain and reverses early cognitive damage caused ...
During doctor's appointments, his pediatrician said it was evident Kingstyn needed speech therapy to overcome ... Speech or language impairment is when an issue with speech, sound production ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results